Citius Oncology Inc.
CTOR
Market Cap$2.8M
Close$
$-0.05
101.2% downside
Current Fair Value
101.2% downsideOvervalued by 101.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.80 Million |
|---|---|
| Enterprise Value | $6.60 Million |
| Dividend Yield | $0 (-%) |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.03 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.58 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data